For Immediate Release:
February 21, 2020
Contact:
James Garrow
james.garrow@phila.gov
215-200-7901
Advisory: City and Health Systems Announce Expansion of Buprenorphine Prescribing Waiver
What:
The Mayor will be joined by representatives from major health systems throughout Philadelphia who are committing to expanding access to buprenorphine, a life-saving medication used to treat opioid addiction, by ensuring that their primary care practitioners obtain the waiver that allows them to prescribe it. This commitment will result in the largest single-year expansion of buprenorphine-waivered providers in Philadelphia and could lead to thousands of people more with opioid use disorder receiving treatment in primary care.
Who:
Jim Kenney, Mayor
Dr. Thomas Farley, Health Commissioner
David Jones, Commissioner of the Department of Behavioral Health and Intellectual disAbilities Services
Dr. Edmund Pribitkin, Executive Vice President, Jefferson Health
Dr. Rohit Gulati, Chief Medical Officer, Einstein Healthcare Network
Dr. Tony Reed, Chief Medical Officer, Temple University Hospital
When:
Monday, February 24, 2020, 9:30 a.m.
Where:
Mayor’s Reception Room, City Hall
# # #
|
|
|
|
